viral
agent
apart
hepat
virus
may
affect
liver
part
system
involv
may
includ
acut
hepat
instanc
acut
liver
failur
may
lead
fulmin
hepat
agent
abil
caus
chronic
liver
diseas
proven
unequivoc
although
seem
unlik
caus
acut
liver
failur
remain
unknown
signific
proport
case
viral
agent
evalu
etiolog
factor
agent
includ
cytomegaloviru
epsteinbarr
viru
herp
simplex
viru
varicella
zoster
viru
human
herpesvirus
human
parvoviru
adenovirus
occult
hepat
b
viru
recent
sarsassoci
coronaviru
human
cytomegaloviru
cmv
largest
member
b
herpesvirida
famili
virus
cytomegali
giant
cell
promin
intranuclear
inclus
bodi
character
cellular
respons
cmv
infect
cmv
infect
quit
common
reach
urban
popul
play
signific
role
opportunist
pathogen
immunocompromis
host
earli
recognit
infect
institut
therapi
prevent
infect
critic
alter
outcom
patient
sever
factor
determin
manifest
sever
cmv
infect
infect
acquir
either
perinat
period
infanc
adulthood
sexual
contact
blood
transfus
organ
transplant
primari
cmv
infect
immunocompet
adult
either
asymptomat
associ
mild
mononucleosislik
syndrom
herp
virus
primari
infect
resolv
enter
lifelong
latenc
live
viru
sequest
nonrepl
state
person
latent
infect
intact
immun
system
symptom
exhibit
antibodi
cmv
circul
lymphocyt
monocyt
polymorphonuclear
leukocyt
may
serv
predomin
site
viral
latenc
risk
intermitt
reactiv
increas
diminish
host
immun
statu
immunocompromis
patient
cmv
diseas
result
either
primari
infect
previous
uninfect
seroneg
host
commonli
reactiv
latent
infect
although
adequ
anticmv
antibodi
detect
episod
reactiv
infect
cellmedi
immun
character
decreas
number
cytotox
lymphocyt
natur
killer
cell
defect
incid
sever
cmv
diseas
close
parallel
degre
cellular
immun
dysfunct
wide
spectrum
clinic
syndrom
associ
cmv
diseas
rang
asymptomat
infect
lifethreaten
congenit
cmv
syndrom
neonat
infecti
mononucleosi
syndrom
young
adult
sever
pulmonari
retin
neurolog
gastrointestin
hepat
diseas
immunocompromis
host
cmv
common
opportunist
pathogen
congenit
cmv
infect
associ
substanti
morbid
mortal
manifest
shortli
birth
jaundic
hepatosplenomegali
thrombocytopen
purpura
sever
neurolog
symptom
multifoc
hepat
necrosi
cytomegal
cell
intranuclear
inclus
bodi
inflammatori
respons
mark
bile
stasi
may
detect
liver
biopsi
child
surviv
jaundic
hepatosplenomegali
may
subsid
neurolog
sequela
mental
retard
persist
differ
form
neonat
cmv
infect
occur
result
perinat
mother
cervix
deliveri
postnat
breastfeed
transmiss
viru
result
clinic
pictur
resembl
mild
infecti
mononucleosi
syndrom
without
neurolog
involv
mild
selflimit
hepat
may
occur
usual
resolv
first
year
life
immunocompet
children
adult
cmv
infect
usual
subclin
sometim
caus
diseas
resembl
ebv
infecti
mononucleosi
syndrom
unlik
ebv
mononucleosi
pharyng
cervic
lymphadenopathi
absent
heterophil
respons
neg
neg
monospot
mode
transmiss
patient
sexual
contact
kiss
intrafamili
transmiss
share
object
contamin
saliva
among
famili
member
blood
transfus
surgic
patient
requir
massiv
blood
transfus
cmv
infect
consid
sourc
postop
fever
sometim
call
postperfus
syndrom
section
v
liver
diseas
due
infecti
agent
liver
dysfunct
commonli
associ
cmv
mononucleosi
usual
mild
rare
symptomat
immunocompet
patient
hepatosplenomegali
laboratori
evid
mild
moder
hepat
dysfunct
predomin
featur
increas
transaminas
alkalin
phosphatas
valu
case
respect
lower
commonli
encount
activ
viral
hepat
rare
manifest
cmv
hepat
includ
tender
hepatomegali
granulomat
hepat
scatter
microscop
granuloma
found
liver
biopsi
anicter
icter
cholestat
form
hepat
acut
hepat
massiv
hepat
necrosi
patient
impair
cellmedi
immun
dissemin
cmv
infect
result
seriou
life
threaten
diseas
cmv
common
opportunist
viral
infect
aid
patient
caus
retin
central
nervou
system
infect
esophag
coliti
cmv
may
also
invad
hepatobiliari
tract
aid
patient
caus
hepat
pancreat
acut
acalcul
gangren
cholecyst
presenc
cytomegaloviru
retin
gastrointestin
diseas
viremia
aid
patient
increas
risk
develop
cholestat
syndrom
caus
papillari
stenosi
scleros
cholang
usual
respond
antivir
therapi
immunocompromis
patient
risk
organ
transplant
recipi
includ
liver
transplant
diagnosi
cmv
hepat
alway
requir
confirmatori
laboratori
test
clinic
present
alon
suffici
establish
diagnosi
serolog
studi
cmv
igm
antibodi
may
help
primari
infect
viral
cultur
techniqu
could
greatli
enhanc
use
shell
vial
assay
use
cmv
earli
antigen
use
molecular
techniqu
detect
cmv
earli
antigen
cmv
dna
polymeras
increas
sensit
detect
cmv
infect
blood
tissu
liver
biopsi
distinct
patholog
find
import
establish
diagnosi
cmv
hepat
especi
immunocompromis
host
giant
multinucl
cell
reaction
inflammatori
respons
multifoc
necrosi
biliari
stasi
commonli
found
larg
nuclear
inclusionbear
cell
sometim
call
owl
eye
inclus
found
hepatocyt
bile
duct
epithelium
treatment
cmv
antivir
agent
alway
indic
especi
selflimit
diseas
immunocompet
adult
sever
worrisom
case
particularli
patient
impair
cellmedi
immun
therapi
lifesav
aciclovir
ineffect
ganciclovir
nucleosid
analog
guanosin
homolog
aciclovir
longer
intracellular
halflif
consid
antivir
agent
choic
cmv
durat
therapi
guid
repeat
measur
cmv
blood
sampl
emerg
resist
strain
ganciclovir
pose
therapeut
challeng
foscarnet
cidofovir
may
becom
altern
antivir
agent
epsteinbarr
viru
ebv
share
characterist
morpholog
featur
herpesvirida
famili
ebv
genom
consist
linear
dna
molecul
encod
nearli
viral
protein
infect
b
lymphocyt
linear
ebv
genom
becom
circular
form
episom
usual
remain
latent
b
cell
viral
replic
spontan
activ
small
percentag
latent
infect
b
cell
transmiss
ebv
usual
occur
via
contact
oral
secret
saliva
droplet
possibl
cell
saliva
transmiss
blood
transfus
report
unusu
viru
replic
nasopharyng
epitheli
cell
nearli
seroposit
person
activ
shed
viru
saliva
b
cell
oropharynx
may
primari
site
infect
rest
memori
b
cell
thought
site
persist
ebv
bodi
research
abl
identifi
variou
clinic
condit
associ
ebv
infecti
mononucleosi
burkitt
lymphoma
nasopharyng
carcinoma
hodgkin
diseas
peripher
tcell
lymphoma
posttranspl
lymphoprolif
diseas
ebv
infect
common
infect
human
worldwid
persist
lifetim
person
hepatosplenomegali
palat
petechia
may
present
symptomat
patient
liver
involv
well
recogn
ebv
infect
manifest
liver
involv
rang
commonli
encount
mild
selflimit
acut
hepat
occasion
report
fatal
acut
fulmin
hepat
mild
elev
aminotransferas
two
three
time
upper
limit
normal
elev
lactic
dehydrogenas
level
seen
case
infecti
mononucleosi
typic
rise
aminotransferas
gradual
reach
peak
lower
commonli
encount
acut
viral
hepat
rise
occur
period
aminotransferas
declin
gradual
week
patient
older
year
gener
sever
diseas
children
mild
elev
alkalin
phosphatas
level
also
seen
mild
hyperbilirubinemia
sever
cholestat
jaundic
right
upper
quadrant
abdomin
pain
may
occur
elderli
patient
jaundic
may
occasion
initi
clinic
present
combin
fever
abdomin
pain
mistaken
extrahepat
biliari
obstruct
jaundic
occur
predominantli
ebv
infect
complic
autoimmun
hemolyt
anemia
occasion
direct
result
virusinduc
cholestasi
occasion
clinic
set
ebv
liver
involv
includ
posttransfus
hepat
granulomat
hepat
fatal
fulmin
hepat
case
granulomat
hepat
serolog
evid
chronic
ebv
infect
found
detail
clinicopatholog
analysi
patient
sporad
fatal
infecti
mononucleosi
describ
markin
et
al
case
fatal
fulmin
hepat
massiv
hepat
necrosi
dissemin
intravascular
coagul
report
immunocompromis
immunocompet
host
diagnosi
infecti
mononucleosi
establish
basi
clinic
featur
laboratori
serolog
find
indic
recent
ebv
infect
common
hematolog
find
includ
leukocytosi
case
predominantli
lymphocytosi
monocytosi
mild
thrombocytopenia
monospot
test
detect
heterophil
antibodi
although
sensit
specif
ebvspecif
igg
igm
antibodi
direct
viral
capsid
antigen
vca
earli
antigen
ebv
antid
antir
nuclear
antigen
ebvna
solubl
complementfix
antigen
anti
improv
sensit
specif
detect
infect
liver
involv
abdomin
ultrasound
may
show
fatti
liver
appear
gallbladd
wall
thicken
vast
major
case
indic
liver
biopsi
may
portal
sinusoid
mononuclear
cell
infiltr
focal
hepat
necrosi
fatti
infiltr
multinucl
giant
cell
seen
particular
util
diagnost
method
situ
hybrid
southern
blot
analysi
polymeras
chain
reaction
identifi
specif
rna
dna
sequenc
organ
involv
differenti
diagnosi
ebv
hepat
includ
viral
hepat
ae
cytomegaloviru
hepat
druginduc
hepat
cervic
lymphadenopathi
less
common
peripher
monocytosi
encount
observ
cmv
hepat
specif
drug
treatment
ebv
infect
aciclovir
inhibit
ebv
vitro
replic
reduc
viral
shed
oropharynx
effect
symptom
infecti
mononucleosi
primarili
due
immun
respons
viru
therefor
recommend
ebv
hepat
antivir
agent
prove
effect
one
singl
report
fulmin
hepat
failur
immunocompet
young
girl
caus
primari
ebv
infect
treat
orthotop
liver
transplant
herp
simplex
viru
common
infect
human
produc
wide
varieti
ill
includ
mucocutan
infect
infect
central
nervou
system
occasion
infect
viscer
organ
clinic
manifest
cours
hsv
infect
depend
mainli
site
involv
host
age
immun
statu
occasion
hsv
viremia
result
viscer
involv
affect
mainli
three
organ
esophagu
lung
liver
liver
involv
occur
follow
set
neonat
infect
pregnanc
immunocompromis
host
rare
immunocompet
adult
neonat
hepat
occur
multiorgan
involv
usual
carri
high
mortal
rate
fulmin
hepat
caus
hsv
first
describ
hass
neonat
liver
adren
necrosi
associ
distinct
intranuclear
inclus
sever
subsequ
report
shown
acut
fulmin
hepat
adren
insuffici
remain
common
caus
death
neonat
dissemin
hsv
infect
delay
institut
antivir
therapi
hsv
await
confirm
diagnosi
result
catastroph
outcom
hsv
hepat
pregnant
women
first
report
seen
context
dissemin
primari
infect
usual
late
gestat
third
trimest
usual
manifest
acut
fulmin
hepat
mucocutan
lesion
present
half
case
therefor
clinic
suspicion
diagnosi
condit
must
high
twentyf
percent
case
diagnos
autopsi
earli
recognit
initi
antivir
therapi
may
revers
otherwis
fatal
process
hsv
uncommon
caus
hepat
immunocompet
patient
mild
asymptomat
elev
transaminas
level
detect
healthi
adult
acut
genit
herp
infect
fulmin
hepat
rise
transaminas
report
associ
favor
outcom
antivir
therapi
immunocompromis
host
hsv
hepat
occur
primari
rare
recurr
infect
triad
fever
leukopenia
markedli
elev
aminotransferas
suggest
diagnosi
liver
biopsi
essenti
establish
diagnosi
hsv
hepat
especi
pregnanc
usual
show
focal
sometim
extens
hemorrhag
coagul
necrosi
hepatocyt
limit
inflammatori
respons
usual
mononuclear
scatter
lymphocyt
typic
intranuclear
inclus
cowdri
type
often
identifi
margin
foci
necrosi
diagnosi
confirm
detect
hsv
dna
sequenc
pcr
sensit
tissu
cultur
method
hsv
hepat
one
infecti
diseas
emerg
associ
rapid
lethal
cours
requir
earli
recognit
institut
antivir
therapi
await
confirm
diagnosi
order
improv
outcom
mayo
clinic
incid
hsv
hepat
report
among
fulmin
hepat
patient
review
highdos
aciclovir
antivir
drug
choic
least
mgkgday
everi
hour
success
use
shanley
report
case
healthi
femal
develop
dissemin
infect
fulmin
hepat
third
trimest
pregnanc
requir
highdos
antivir
therapi
result
erad
hsv
mucocutan
lesion
howev
patient
condit
continu
deterior
lead
orthotop
liver
transplant
recurr
observ
suggest
dissemin
hsv
infect
absolut
contraind
transplant
certain
clinic
set
recent
publish
seri
demonstr
util
liver
transplant
set
varicella
zoster
viru
caus
two
distinct
clinic
diseas
varicella
commonli
call
chickenpox
primari
infect
character
benign
gener
exanthemat
rash
recurr
infect
result
local
phenomenon
known
herp
zoster
often
call
shingl
rare
noncutan
manifest
enceph
pneumon
myocard
hepat
may
accompani
skin
rash
especi
immunocompromis
patient
may
lifethreaten
mild
transient
liver
enzym
abnorm
uncommon
varicella
infect
children
occur
primari
infect
immunocompet
adult
may
caus
sever
acut
hepat
increas
transaminas
sometim
fulmin
hepat
failur
evid
vzv
liver
organ
reveal
autopsi
contrast
rather
benign
cours
zoster
reactiv
infect
set
organ
transplant
primari
varicella
infect
quit
aggress
viscer
involv
includ
liver
may
occur
immedi
postop
period
may
delay
sever
month
transplant
usual
associ
rapid
onset
fatal
fulmin
hepat
serolog
test
littl
use
especi
immunocompromis
patient
confirm
diagnosi
possibl
isol
vzv
skin
lesion
affect
organ
liver
biopsi
often
show
foci
coagul
necrosi
intranuclear
inclus
inflammatori
respons
pcr
immunoperoxidas
techniqu
may
need
distinguish
vzv
hsv
hepat
cdc
guidelin
prevent
control
nosocomi
infect
must
institut
infect
control
hospit
personnel
earli
administr
antivir
therapi
critic
set
vzv
hepat
especi
immunocompromis
patient
drug
choic
intraven
aciclovir
mgkgday
three
divid
dose
day
human
herp
infect
nearli
human
age
year
usual
caus
exanthema
subitum
roseola
infantum
sixth
diseas
infantil
fever
without
rash
febril
seizur
occasion
enceph
liver
involv
infect
investig
attempt
prove
etiolog
associ
inconclus
elev
aminotransferas
level
appreci
common
featur
roseola
larg
case
seri
pcr
techniqu
situ
hybrid
led
isol
liver
tissu
infant
chronic
hepat
suggest
caus
agent
reactiv
infect
may
occur
solid
organ
transplant
question
clinic
signific
foscarnet
better
vitro
viru
sensit
aciclovir
ganciclovir
recent
studi
report
involv
patient
nona
none
hepat
underw
liver
transplant
acut
liver
failur
antigen
analyz
explant
liver
immunohistochemistri
possibl
presenc
viru
peripher
blood
mononuclear
cell
demonstr
antigenemia
test
involv
hepat
virus
viral
agent
cmv
exclud
patient
acut
liver
failur
unknown
caus
demonstr
antigen
liver
patient
also
demonstr
antigenemia
virus
found
liver
patient
acut
liver
failur
alf
observ
led
author
specul
may
caus
alf
although
report
caus
acut
hepat
fatal
fulmin
hepat
failur
fhf
demonstr
blood
liver
sampl
patient
report
necessarili
establish
causal
also
infect
human
age
year
caus
febril
syndrom
hepat
associ
infrequ
report
also
call
kaposi
sarcomaassoci
human
herp
detect
consist
kaposi
sarcoma
lymphoma
multicentr
castleman
diseas
hivposit
patient
occasion
hivneg
patient
liver
involv
may
occur
viscer
type
kaposi
sarcoma
human
parvoviru
small
dna
viru
discov
incident
parvoviruslik
particl
note
serum
specimen
asymptomat
blood
donor
test
hepat
b
surfac
antigen
sampl
number
panel
b
henc
gave
anomal
fals
posit
result
later
recogn
member
parvovirida
famili
human
parvoviru
infect
produc
spectrum
clinic
manifest
includ
erythema
infectiosum
fifth
diseas
children
hydrop
fetali
fetal
death
arthriti
syndrom
associ
acut
infect
adult
hematolog
disord
leukopenia
thrombocytopenia
transient
aplast
crisi
patient
chronic
hemolyt
anemia
chronic
anemia
immunocompromis
patient
includ
aid
rare
organ
involv
includ
neurolog
cardiac
liver
vascul
hepat
manifest
rang
transient
elev
serum
aminotransferas
sometim
seen
cours
erythema
infectiosum
fulmin
hepat
failur
fhf
dna
found
liver
sampl
patient
nona
none
fhf
aplast
anemia
patient
cryptogen
fhf
without
aplast
anemia
compar
control
subject
chronic
liver
failur
led
investig
suggest
possibl
caus
agent
fulmin
liver
failur
definit
diagnosi
acut
infect
reli
detect
igm
viral
dna
pcr
much
sensit
detect
viral
dna
serum
bodi
fluid
fresh
paraffinembed
tissu
case
infect
benign
selflimit
requir
treatment
symptomat
relief
mayo
clinic
report
two
case
less
sever
form
hepatitisassoci
aplast
anemia
close
serotyp
adenoviru
caus
acut
infect
respiratori
system
conjunctiva
gastrointestin
tract
occasion
hemorrhag
cystiti
infantil
diarrhea
intussuscept
central
nervou
system
infect
dissemin
diseas
multiorgan
involv
report
immunocompromis
patient
associ
increas
mortal
role
adenoviru
etiolog
agent
hepat
damag
controversi
fatal
case
adenoviru
infect
fulmin
hepat
report
immunosuppress
adult
patient
postmortem
liver
patholog
reveal
widespread
hepat
necrosi
intranuclear
inclus
within
viabl
hepatocyt
electron
microscopi
may
show
crystallin
array
virion
within
hepatocyt
specif
therapi
adenoviru
hepat
current
avail
occult
cryptic
hepat
b
viru
hbv
infect
defin
detect
hbv
dna
serum
liver
tissu
patient
neg
hepat
b
surfac
antigen
hbsag
suggest
occult
hbv
infect
maintain
prooncogen
properti
lead
hepatocellular
carcinoma
hcc
hbsagseroneg
patient
occult
hbv
infect
first
report
hybrid
techniqu
detect
hbv
dna
becam
avail
studi
show
hbv
dna
could
detect
hbsagneg
patient
hepatocellular
carcinoma
hcc
recent
studi
use
sensit
techniqu
confirm
observ
usual
patient
occult
hbv
infect
low
hbv
dna
level
copiesml
serum
copi
per
liver
cell
therefor
detect
occult
hbv
infect
often
requir
ultrasensit
polymeras
chain
reaction
pcr
assay
pollicino
et
al
investig
preval
molecular
statu
occult
hbv
infect
among
italian
patient
hcc
test
tumor
tissu
patient
hcc
correspond
nontumor
liver
tissu
patient
hbv
dna
util
ultrasensit
pcr
assay
case
hepat
b
surfac
antigen
neg
viral
dna
detect
case
tumor
tissu
hcc
adjac
benign
tissu
suggest
occult
hbv
risk
factor
develop
hcc
observ
suggest
mechan
oncognesi
describ
patient
overt
hbv
infect
hbsag
posit
oper
patient
occult
hbv
infect
see
chapter
futur
studi
need
determin
exact
role
occult
hbv
infect
develop
hcc
sar
newli
recogn
sever
febril
respiratori
ill
caus
previous
unknown
coronaviru
sarsassoci
coronaviru
sarscov
respons
first
epidem
centuri
emerg
southern
chines
provinc
guangdong
novemb
worldwid
epidem
trigger
late
februari
ill
physician
guangdong
infect
sever
guest
hotel
hong
kong
peopl
subsequ
becam
index
patient
larg
outbreak
sar
mani
area
world
march
world
health
organ
issu
histor
global
alert
sar
deadli
new
infecti
diseas
potenti
rapid
spread
person
person
via
intern
air
travel
partner
includ
center
diseas
control
prevent
cdc
promptli
initi
rapid
intens
coordin
investig
control
effort
led
within
week
identif
etiolog
agent
sarscov
seri
decis
effect
contain
effort
time
sarscov
transmiss
brought
end
juli
case
death
report
cdc
publish
guidelin
order
local
healthcar
facil
develop
oper
prepared
respons
plan
lymphocytopenia
thrombocytopenia
elev
level
ddimer
activ
partial
thromboplastin
time
common
laboratori
find
sar
level
alanin
aminotransferas
creatin
kinas
lactat
dehydrogenas
may
increas
howev
laboratori
find
allow
reliabl
discrimin
sar
caus
communityacquir
pneumonia
onethird
patient
sar
improv
twothird
develop
persist
fever
worsen
pulmonari
symptom
radiograph
find
patient
develop
multiorgan
failur
die
age
coexist
ill
especi
diabet
mellitu
heart
diseas
consist
found
independ
prognost
factor
need
intens
care
risk
death
liver
involv
sar
common
report
patient
major
treat
antibiot
antivir
medic
steroid
potenti
hepatotox
henc
whether
sarscov
infect
lead
liver
damag
per
se
remain
unknown
common
abnorm
elev
aminotransferas
less
common
ischem
injuri
case
multiorgan
failur
howev
chua
et
al
report
clinic
cours
liver
patholog
three
sar
patient
liver
impair
three
moder
mark
elev
liver
aminotransferas
common
caus
hepat
exclud
serolog
test
histolog
examin
liver
specimen
reveal
promin
mitos
acidophil
bodi
kupffer
cell
balloon
hepatocyt
mild
moder
lobular
inflamm
common
histolog
featur
patient
show
posit
rtpcr
sarscov
liver
tissu
sera
suggest
viru
local
liver
investig
conclud
sarscov
may
infect
liver
lead
mild
moder
lobular
inflamm
apoptosi
addit
hepat
agent
suggest
transfusionassoci
hepat
studi
cdc
sentinel
counti
studi
case
fulmin
hepat
agent
identifi
major
condit
viral
agent
suspect
exist
specif
viru
identifi
gb
agent
hepat
g
viru
hgv
rna
virus
belong
flavivirida
famili
extens
investig
fail
show
agent
play
etiolog
role
acut
chronic
liver
diseas
tt
viru
ttv
shown
small
nonenvelop
singlestrand
circular
dna
viru
famili
circovirida
clear
ttv
heterogen
agent
transmit
human
parenter
nonparenter
rout
agent
particularli
high
preval
japan
ttv
detect
healthi
person
although
initi
implic
fulmin
hepat
cryptogen
chronic
liver
diseas
associ
confirm
current
proven
hepat
diseas
associ
agent
newli
describ
virus
famili
design
sanban
yonban
agent
similar
properti
ttv
suffici
nucleotid
differ
make
distinct
member
circovirida
famili
sen
viru
senv
discov
independ
use
amplif
strategi
highli
degener
ttv
primer
two
senv
variant
send
sench
studi
found
acut
infect
transfusiontransmit
nona
none
hepat
case
current
evid
senv
truli
hepat
viru
work
need
